Exhibitors Search
㈜입셀
Booth no.
A32
|
Exhibition
|
| |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
| |
|
Tel
|
|-- |
|
Exhibits
|
| iPSC-based osteoarthritis cell therapy(MIUChon™, Minimal Injectable Unit Chondrospheroid), iPSC technology-based services - Clinical/RUO-grade cell lines, Disease modeling platforms, and Drug Development & Screening |
|
Company Type
|
| |
Exhibitor Information
Exhibit/Technology Introduction (General)
MIUChon™ is an advanced cell therapy composed of chondrocytes differentiated from induced pluripotent stem cells (iPSCs). Using our patented technology, these chondrocytes are aggregated and organized into three-dimensional spheroids?referred to as chondrocyte aggregates (Chondrospheroids)?which are directly administered into the joint cavity.
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : MIUChon™An advanced cell therapy that directly injects chondrocyte aggregates (chondrospheroids) differentiated from induced pluripotent stem cells (iPSCs) into the joint cavity.
KYUNGYON EXHIBITION CORP.
